TheWealthWeb

PGIM India Healthcare Fund Growth Regular

PGIM India Mutual FundEquity Schemes - Thematic FundRegular · GrowthRisk: Very High

NAV ₹12.47 on 13 November 2026

AMFI name: PGIM India Healthcare Fund - Regular Plan - Growth Option · Scheme code 153040 · ISIN INF663L01Z52

1 year
+24.20%
Since launch, a year
+12.29%
NAV performance, last year

Returns

To 13 November 2026. Up to 1 year: total change. 3 and 5 years: compound return a year.

PeriodThis fundNIFTY HEALTHCARE INDEX TRICategory median
1M+8.81%+8.67%+5.49%
6M+15.78%+12.84%+7.01%
1Y+24.20%+38.92%+3.50%
3Y-+28.05%+13.93%
5Y--+10.43%

Benchmark: NIFTY HEALTHCARE INDEX TRI (total return index), measured over the same dates. The scheme document names BSE Healthcare TRI, which we do not hold, so this is the closest NSE index.

Category median: the middle return among Regular plans (Growth option) in AMFI's “Equity Schemes - Thematic Fund” category, up to 61 funds with clean data. Ranks are under “Rank among peers”.

Risk

From daily NAVs. Alpha, beta and capture are measured against NIFTY HEALTHCARE INDEX TRI.

Volatility
13.06%
Annualised, 1 year
Max drawdown
-14.58%
Worst fall from a peak, 3 years
Sharpe ratio
1.39
Return above the risk-free rate per unit of volatility, 1 year
Sortino ratio
0.70
Like Sharpe, counting only falls, 3 years
Alpha
+0.25%
Return a year beyond what beta explains, 3 years
Beta
0.43
1.00 moves in step with the benchmark, 3 years
Upside capture
53%
Share of the benchmark's rises captured, 3 years
Downside capture
88%
Share of the benchmark's falls taken (lower is better), 3 years

Rank among peers

Regular plans, Growth option, in AMFI's “Equity Schemes - Thematic Fund” category. Each rank counts only the peers that have that figure.

Compare with Top Peers
3-Year Return Rank
-of 142
-
N/A
Q1
Q2
Q3
Q4
1-Year Return RankQ1
#8of 233
+24.20%
Ahead of 225 of the other 232
Q1
Q2
Q3
Q4
Sharpe (Risk-Adjusted)Q1
#3of 232
1.39
Ahead of 229 of the other 231
Q1
Q2
Q3
Q4
Highest 3-year returns in the categoryRegular plans · Growth option
RankScheme Name3Y Return1Y ReturnSharpeDirect TERAUM
#1
Nippon India Mutual Fund
+46.52%+60.64%1.071.06%₹1,100 Cr
#2
HDFC Mutual Fund
+33.64%+20.34%1.070.89%₹11,128 Cr
#3
HDFC Mutual Fund
+31.28%+31.60%1.761.03%₹3,128 Cr
#4
SBI Mutual Fund
+25.42%+26.07%1.470.76%₹5,565 Cr
#5
HDFC Mutual Fund
+24.77%+10.10%1.091.10%₹1,997 Cr
#6
Mirae Asset Mutual Fund
+24.42%+27.89%1.28-₹3,458 Cr
#7
UTI Mutual Fund
+23.89%+22.00%1.311.35%₹1,399 Cr
#8
ICICI Prudential Mutual Fund
+22.73%+10.29%0.952.08%₹3,926 Cr
#-
PGIM India Healthcare Fund GrowthCurrent Fund
PGIM India Mutual Fund
-+24.20%1.390.98%₹118 Cr

Costs and fund facts

Expense ratio (stated maximum)
Direct 0.98% · Regular 2.65%
Exit load
For Exits within 90 days from date of allotment of units: 0.50%; For Exits beyond 90 days from date of allotment of units: NIL.
Fund size (all plans)
₹118 CrAverage, quarter to September 2026
Benchmark
BSE Healthcare TRICompared here with NIFTY HEALTHCARE INDEX TRI
Allotment date
6 December 2024Scheme document
Type
An open ended equity scheme investing in healthcare and pharmaceutical theme.
AMFI scheme code
153040

Fund managers (3)

  • Anandha Padmanabhan Anjeneyansince 06-Dec-2024
  • Utsav Mehtasince 06-Dec-2024
  • Vivek Sharma and Mr. Puneet Palsince 06-Dec-2024

How each manager has done since taking over: fund manager scorecard.

Investment objective

The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there is no assurance that the investment objective of the scheme will be achieved. The Scheme does not guarantee/ indicate any returns.

From the scheme summary document filed with AMFI.

SIP calculator

A monthly SIP replayed on this fund's actual daily NAVs: what it would be worth today.

Monthly SIP Amount₹10,000
Investment Horizon5 Years
Simulating monthly 1st from 11 Dec 2024 to 13 Nov 2026
Total Invested24 mos
₹2,40,000
Units: 23,702.575
Current Portfolio Value
₹2,95,571
At latest recorded NAV
Total Profit
+₹55,571
+23.2% absolute return
SIP XIRR
22.58%
Annualised, money-weighted
Wealth CompositionProfit is 23% of total invested capital
Invested: ₹2,40,000Profit Generated: ₹55,571
Same SIP in the benchmark (NIFTY HEALTHCARE INDEX TRI)Same dates & amounts
Scheme SIP Valuation
₹2,95,571
22.6% XIRR
Benchmark SIP Valuation
₹5,56,767
25.8% XIRR
Fund minus benchmark
₹-2,61,196
Over 24 monthly installments
SIP instalments are bought on the first NAV date of each month; values use the latest NAV we hold. Past returns are not a guide to future returns.

About this fund

PGIM India Healthcare Fund Growth Regular is a mutual fund scheme from PGIM India Mutual Fund, listed by AMFI under “Equity Schemes - Thematic Fund”. This page covers the Regular plan with the Growth option. Its NAV was ₹12.47 on 13 November 2026. It returned 24.20% over 1 year, measured from NAVs (3- and 5-year figures are annualised). Its benchmark, NIFTY HEALTHCARE INDEX TRI, returned 38.92% over 1 year. Q-Score: 66 out of 100, rated only against funds in the same category. The fund house rates its risk as “Very High” on the SEBI riskometer. Its average assets under management were ₹118 Cr across all plans for the quarter ending September 2026, as reported to AMFI. Its scheme summary document states a maximum expense ratio (TER) of 2.65% a year for the Regular plan. Managed by Anandha Padmanabhan Anjeneyan, Utsav Mehta and Vivek Sharma and Mr. Puneet Pal. Its scheme summary document gives the allotment date as 6 December 2024.

Figures are calculated from AMFI NAVs and index data, not taken from fund factsheets. Methodology. Past performance is not a guide to future returns.

Plans and options of this fund (2)

PlanOptionISINAMFI codeNAV
DirectIDCWINF663L01Z45153037₹12.8913 Nov 2026
DirectIDCWINF663L01Z45153037₹12.8913 Nov 2026